| The pathogenesis and treatment of kidney stones FL Coe, JH Parks, JR Asplin New England Journal of Medicine 327 (16), 1141-1152, 1992 | 957 | 1992 |
| Effects of phosphate binders in moderate CKD GA Block, DC Wheeler, MS Persky, B Kestenbaum, M Ketteler, ... Journal of the American Society of Nephrology: JASN 23 (8), 1407, 2012 | 622 | 2012 |
| Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease SM Moe, MP Zidehsarai, MA Chambers, LA Jackman, JS Radcliffe, ... Clinical journal of the American Society of Nephrology: CJASN 6 (2), 257, 2011 | 572 | 2011 |
| Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6 Z Jiang, JR Asplin, AP Evan, VM Rajendran, H Velazquez, TP Nottoli, ... Nature genetics 38 (4), 474-478, 2006 | 315 | 2006 |
| The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass EA Odstrcil, JG Martinez, CA Santa Ana, B Xue, RE Schneider, KJ Steffer, ... The American journal of clinical nutrition 92 (4), 704-713, 2010 | 230 | 2010 |
| NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy F Knauf, JR Asplin, I Granja, IM Schmidt, GW Moeckel, RJ David, ... Kidney international 84 (5), 895-901, 2013 | 217 | 2013 |
| Hyperoxaluria in kidney stone formers treated with modern bariatric surgery JR Asplin, FL Coe The Journal of urology 177 (2), 565-569, 2007 | 206 | 2007 |
| Nephrolithiasis JR Asplin Nephrology Secrets, 123-130, 2012 | 193 | 2012 |
| Hyperoxaluric calcium nephrolithiasis JR Asplin Endocrinology and Metabolism Clinics 31 (4), 927-949, 2002 | 186 | 2002 |
| Evidence of calcium phosphate supersaturation in the loop of Henle JR Asplin, NS Mandel, FL Coe American Journal of Physiology-Renal Physiology 270 (4), F604-F613, 1996 | 177 | 1996 |
| A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis JH Parks, E Goldfisher, JR Asplin, FL Coe The Journal of urology 167 (4), 1607-1612, 2002 | 173 | 2002 |
| Contribution of human uropontin to inhibition of calcium oxalate crystallization JR Asplin, D Arsenault, JH Parks, FL Coe, JR Hoyer Kidney international 53 (1), 194-199, 1998 | 170 | 1998 |
| Molecular modifiers reveal a mechanism of pathological crystal growth inhibition J Chung, I Granja, MG Taylor, G Mpourmpakis, JR Asplin, JD Rimer Nature 536 (7617), 446-450, 2016 | 168 | 2016 |
| Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals JR Hoyer, JR Asplin, L Otvos Jr Kidney international 60 (1), 77-82, 2001 | 157 | 2001 |
| Uric acid stones. JR Asplin Seminars in nephrology 16 (5), 412-424, 1996 | 151 | 1996 |
| Obesity and urolithiasis JR Asplin Advances in chronic kidney disease 16 (1), 11-20, 2009 | 134 | 2009 |
| Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats DA Bushinsky, JR Asplin, MD Grynpas, AP Evan, WR Parker, ... Kidney international 61 (3), 975-987, 2002 | 131 | 2002 |
| Specificity of growth inhibitors and their cooperative effects in calcium oxalate monohydrate crystallization S Farmanesh, S Ramamoorthy, J Chung, JR Asplin, P Karande, JD Rimer Journal of the American Chemical Society 136 (1), 367-376, 2014 | 122 | 2014 |
| Effect of grapefruit juice on urinary lithogenicity DS GOLDFARB, JR ASPLIN The Journal of urology 166 (1), 263-267, 2001 | 120 | 2001 |
| Clinical use of cystine supersaturation measurements Y Nakagawa, JR ASPLIN, DS GOLDFARB, JH PARKS, FL COE The Journal of urology 164 (5), 1481-1485, 2000 | 118 | 2000 |
